Variant report
Variant | nsv558705 |
---|---|
Chromosome Location | chr12:43017525-43022946 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:10)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:10 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CHD2 | chr12:43019491-43019597 | K562 | blood: | n/a | n/a |
2 | MXI1 | chr12:43018683-43018684 | HepG2 | liver: | n/a | n/a |
3 | NFIC | chr12:43019321-43019865 | ECC-1 | luminal epithelium: | n/a | n/a |
4 | NFYA | chr12:43019379-43019678 | K562 | blood: | n/a | chr12:43019530-43019548 chr12:43019554-43019572 |
5 | NFYA | chr12:43019481-43019684 | Hela-S3 | cervix: | n/a | chr12:43019530-43019548 chr12:43019554-43019572 |
6 | NFYB | chr12:43019303-43019703 | K562 | blood: | n/a | chr12:43019560-43019575 chr12:43019536-43019551 chr12:43019512-43019527 |
7 | NFYB | chr12:43019379-43019617 | GM12878 | blood: | n/a | chr12:43019560-43019575 chr12:43019536-43019551 chr12:43019512-43019527 |
8 | NFYB | chr12:43019394-43019613 | Hela-S3 | cervix: | n/a | chr12:43019560-43019575 chr12:43019536-43019551 chr12:43019512-43019527 |
9 | POLR2A | chr12:43018918-43019033 | GM12878 | blood: | n/a | n/a |
10 | POLR2A | chr12:43019211-43019398 | GM12878 | blood: | n/a | n/a |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000257687 | TF binding region |
ENSG00000257405 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs17091487 | chr12:43017525-43017526 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs35846624 | chr12:43017550-43017551 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs77995741 | chr12:43017561-43017562 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs143097881 | chr12:43017573-43017574 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs147518605 | chr12:43017576-43017577 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs17091490 | chr12:43017581-43017582 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs115173767 | chr12:43017655-43017656 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs79128145 | chr12:43017671-43017672 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs185258876 | chr12:43017673-43017674 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs12315486 | chr12:43017679-43017680 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs549312835 | chr12:43017772-43017773 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs561597216 | chr12:43017800-43017801 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs528796319 | chr12:43017811-43017812 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs146290209 | chr12:43017817-43017818 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs546921150 | chr12:43017864-43017865 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs529526847 | chr12:43017867-43017868 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs140057524 | chr12:43017878-43017879 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs570885973 | chr12:43018053-43018054 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs555388808 | chr12:43018070-43018071 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs142988109 | chr12:43018092-43018093 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs573700879 | chr12:43018106-43018107 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs117724518 | chr12:43018124-43018125 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs150684651 | chr12:43018147-43018148 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs12426290 | chr12:43018151-43018152 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs554484178 | chr12:43018153-43018154 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs566694326 | chr12:43018178-43018179 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs533824188 | chr12:43018193-43018194 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs563218530 | chr12:43018197-43018198 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs71281676 | chr12:43018201-43018202 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs67282426 | chr12:43018202-43018203 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs60057468 | chr12:43018203-43018204 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs12426303 | chr12:43018212-43018213 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs545428964 | chr12:43018214-43018215 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs369759974 | chr12:43018216-43018217 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs563378044 | chr12:43018240-43018241 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs139045881 | chr12:43018292-43018293 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs561305852 | chr12:43018332-43018333 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs189730847 | chr12:43018350-43018351 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs540518095 | chr12:43018385-43018386 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs565249715 | chr12:43018393-43018394 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs566433679 | chr12:43018435-43018436 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs77262338 | chr12:43018484-43018485 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs74819725 | chr12:43018501-43018502 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs117347473 | chr12:43018522-43018523 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs7138749 | chr12:43018536-43018537 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs7305260 | chr12:43018562-43018563 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs566546142 | chr12:43018604-43018605 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs12146760 | chr12:43018621-43018622 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs76374467 | chr12:43018656-43018657 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs80297514 | chr12:43018687-43018688 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Seminomas | 18059402 | CNVD |
Wilms tumour | 21544195 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Breast cancer | 21949216 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21637783 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 21183584 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Lissencephaly | 21572526 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Breast cancer | 19602461 | CNVD |
Breast cancer | 17899364 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Breast cancer | 21364760 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22522925 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:43017000-43020800 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
2 | chr12:43018200-43019200 | Enhancers | Primary monocytes fromperipheralblood | blood |
3 | chr12:43018400-43019200 | Enhancers | Monocytes-CD14+_RO01746 | blood |
4 | chr12:43020800-43021000 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
5 | chr12:43020800-43021200 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
6 | chr12:43021000-43021800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
7 | chr12:43021400-43022000 | Enhancers | Fetal Stomach | stomach |